Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paricalcitol PK and Tolerability in CKD Stage 5
NCT00646932Phase 2Completed
- Sponsor
- Abbott Laboratories
- Start
- Nov 2005
- Primary completion
- Feb 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of paricalcitol in secondary hyperparathyroidism (SHPT), sponsored by Abbott Laboratories. Started Nov 2005; status: completed.
02
Drugs
paricalcitol
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT00646932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00646932.